脊髓刺激设备市场－全球产业规模、份额、趋势、机会及预测（依产品类型、应用、最终用户、地区及竞争格局划分），2021-2031年

全球脊髓刺激设备市场预计将从 2025 年的 39.8 亿美元成长到 2031 年的 68.8 亿美元，复合年增长率达到 9.55%。

这些植入式神经调控系统透过向脊髓传递电脉衝来阻断疼痛讯号，使其成为治疗方法慢性神经病变疼痛的重要手段。市场成长的主要驱动因素包括全球慢性疼痛综合症发病率的上升、人口老化以及临床治疗转向非阿片类镇痛药物。美国国家疼痛基金会近期发布的统计数据凸显了这一巨大需求：预计到2024年，美国将有5,160万成年人患有慢性疼痛，显示对先进治疗方案的需求十分旺盛。

然而，由于监管机构对这些设备的长期安全性和有效性审查日益严格，市场扩张面临巨大的阻力。监管机构正在对上市前临床证据和上市后监测实施更严格的标准，以最大限度地减少导线移位和感染等併发症。这些严格的监管措施，加上植入手术的高成本以及不同医疗体系中复杂的报销机制，造成了财务和程序上的障碍，限制了患者更广泛地获得和使用该技术。

市场驱动因素

推动全球脊髓刺激设备市场发展的关键因素是慢性疼痛疾病的日益增加以及非鸦片类药物治疗策略的强劲成长。随着医疗基础设施逐步改善以应对鸦片类药物危机，植入式神经调控疗法正逐渐成为保守治疗无效患者的首选长期解决方案。近期流行病学数据也印证了这项需求的迫切性。美国疾病管制与预防中心 (CDC) 在其 2024 年 11 月发布的《发病率和死亡率週报》中指出，2023 年美国成年人中慢性疼痛的盛行率为 24.3%，这表明介入治疗拥有庞大的目标族群。

此外，新一代脊髓刺激（SCS）技术的进步正在推动市场发展，这些技术提高了治疗效果和患者依从性。技术创新已从标准的连续刺激发展到先进的封闭回路型系统，该系统能够自动适应神经波动，从而改善临床疗效并降低消融率。这项技术进步也体现在主要产业领导者的财务表现。波士顿科学公司在2024年10月发布的「2024财年第三季财报」中指出，其神经调控收入成长了17%，这主要得益于其先进的设备组合。同样，美敦力公司在2024年8月发布的「第一季财报」中也显示，其神经科学产品组合的营收已增至23亿美元，证实了这些神经刺激技术的强劲商业性潜力。

市场挑战

全球脊髓刺激设备市场的成长受到复杂报销体系和严格程序障碍的显着限制，限制了患者获得这些先进治疗方法。保险公司和医疗系统日益实施严格的核准流程，并要求提供保守治疗失败的详细记录，方可批准核准。这些行政障碍导致治疗交付严重延误，常常迫使患者彻底放弃治疗。最终形成瓶颈，由于支付方的限制，患者的高需求无法转化为实际的设备植入。

美国医学会 (AMA) 的数据凸显了这些程序性挑战的严重性：该协会报告称，2024 年，93% 的医生认为事先核准程序会显着延误患者必要的治疗。这项统计数据显示了市场面临的障碍规模之大。当医疗服务提供者被迫进行耗费资源且结果不确定的核准流程时，提供这些专业服务的经济可行性就会降低。这反过来又会阻碍脊髓刺激技术的广泛应用，并削弱市场应对日益普遍的慢性疼痛的能力。

市场趋势

塑造市场格局的关键趋势是技术进步推动植入式脉衝产生器 (IPG) 和微型刺激器体积显着缩小，创伤更小。这些紧凑型设备能够缩小手术切口，提高患者舒适度，并增加植入位置的柔软性，从而直接解决患者对植入部位疼痛和装置可见度的担忧。向微创解决方案的转变得到了大量投资的支持。例如，Nalu Medical, Inc. 在 2024 年 3 月发布的题为「Nalu Medical, Inc. 完成 E 轮融资 8,500 万美元」的新闻稿中披露，该公司已获得 8,500 万美元的股权资金筹措，用于加速其微型神经刺激系统的商业性扩张。

同时，无线连接和行动应用程式的普及正大力推动远端患者监护的发展，使临床医生无需频繁到诊即可追踪使用数据并调整设定。这种数位化整合提高了患者参与度，简化了护理流程，尤其对居住在偏远地区、需要持续治疗监督的患者更是如此。这种互联护理模式的正面影响在近期的市场表现中显而易见。在2024年10月发布的《雅培公布2024年第三季业绩》中，雅培报告称，其医疗设备部门的收入增长了11.7%，部分原因是其互联神经调控产品线的成功应用，该产品线支持无缝远端系统管理。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球脊髓刺激设备市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品类型（可充电式与不可充电式）
  • 依应用领域（腰椎手术后症候群、复杂性局部疼痛症候群、椎间盘退化性疾病、椎间盘手术失败等）
  • 按最终使用者（医院/诊所、门诊护理中心、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美脊髓刺激设备市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲脊髓刺激设备市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章 亚太地区脊髓刺激设备市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲脊髓刺激设备市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美脊髓刺激设备市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球脊髓刺激设备市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Abbott Laboratories
• Medtronic plc
• Boston Scientific Corporation
• Nevro Corporation
• Stimwave LLC
• Nuvectra Corporation
• Biotronik SE & Co. KG
• Mainstay Medical International plc
• Nevro Inc.
• Sapiens Spine LLC

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Spinal Cord Stimulation Devices Market is projected to expand from USD 3.98 Billion in 2025 to USD 6.88 Billion by 2031, achieving a CAGR of 9.55%. These implantable neuromodulation systems function by transmitting electrical impulses to the spinal cord to intercept pain signals, serving as a vital treatment for chronic neuropathic pain. Market growth is largely propelled by the rising global incidence of chronic pain syndromes, an aging population, and a clinical shift towards non-opioid pain management. This substantial need is highlighted by recent statistics from the U.S. Pain Foundation, which reported in 2024 that 51.6 million adults in the United States live with chronic pain, emphasizing the critical demand for advanced therapeutic solutions.

However, market expansion faces significant headwinds due to heightened regulatory scrutiny concerning the long-term safety and efficacy of these devices. Regulatory bodies are imposing stricter standards for pre-market clinical evidence and post-market surveillance to minimize complications such as lead migration or infection. These rigorous oversight measures, combined with the high costs associated with implantation procedures and complex reimbursement frameworks across various healthcare systems, establish economic and procedural hurdles that restrict broader patient access and technology adoption.

Market Driver

The primary engines driving the Global Spinal Cord Stimulation Devices Market are the increasing frequency of chronic pain disorders and a resolute transition toward non-opioid management strategies. As healthcare infrastructure seeks to combat the opioid epidemic, implantable neuromodulation has emerged as a favored long-term solution for patients who have not found relief through conservative treatments. The urgency of this demand is reinforced by recent epidemiological data; the Centers for Disease Control and Prevention noted in their November 2024 'Morbidity and Mortality Weekly Report' that 24.3 percent of adults in the United States experienced chronic pain in 2023, representing a vast population eligible for interventional therapies.

Furthermore, the market is propelled by advancements in next-generation SCS technologies that improve therapeutic effectiveness and patient adherence. Innovation has evolved from standard tonic stimulation to sophisticated closed-loop systems that automatically adapt to neural variations, thereby enhancing clinical outcomes and decreasing explant rates. This technological progress is reflected in the financial results of major industry leaders; Boston Scientific reported in their 'Third Quarter 2024 Financial Results' in October 2024 that their Neuromodulation segment sales grew by 17 percent due to advanced device portfolios. Similarly, Medtronic's 'First Quarter Fiscal Year 2025 Financial Results' from August 2024 showed Neuroscience portfolio revenue rising to 2.3 billion U.S. dollars, confirming the strong commercial viability of these neurostimulation technologies.

Market Challenge

The growth of the Global Spinal Cord Stimulation Devices Market is severely constrained by complicated reimbursement frameworks and strict procedural barriers that limit patient access to these sophisticated therapies. Insurance providers and healthcare systems increasingly enforce rigorous prior authorization processes and demand extensive documentation of failed conservative treatments before granting coverage approval. These administrative obstacles cause substantial delays in the delivery of care, frequently leading patients to abandon the treatment process altogether, creating a bottleneck where high patient demand fails to translate into device implantations due to payer restrictions.

The severity of these procedural challenges is highlighted by data from the American Medical Association, which reported in 2024 that 93% of physicians found prior authorization processes to significantly delay necessary patient care. This statistical evidence illustrates the scale of the obstacles confronting the market. When healthcare providers are compelled to navigate resource-heavy approval procedures with uncertain results, the economic viability of providing these specialized services declines, thereby discouraging the widespread adoption of spinal cord stimulation technologies and hindering the market's capacity to address the growing prevalence of chronic pain.

Market Trends

A key trend shaping the market is the technological drive toward developing significantly smaller and less invasive implantable pulse generators (IPGs) and micro-stimulators. These compact devices allow for smaller surgical incisions, enhance patient comfort, and offer greater flexibility in placement, directly addressing patient concerns regarding implant site pain and device visibility. The shift toward minimally invasive solutions is supported by substantial investment; for instance, Nalu Medical, Inc. announced in a March 2024 press release titled 'Nalu Medical, Inc. Closes $85 Million Series E Round' that it raised 85 million U.S. dollars in equity financing explicitly to accelerate the commercial expansion of its miniaturized neurostimulation system.

Concurrently, the incorporation of wireless connectivity and mobile applications is fostering a strong movement toward remote patient monitoring, enabling clinicians to track usage data and adjust settings without requiring frequent in-clinic visits. This digital integration improves patient engagement and streamlines care, particularly for individuals in remote locations who need consistent therapeutic supervision. The positive impact of this connected care model is evident in recent market performance; Abbott reported in its 'Abbott Reports Third-Quarter 2024 Results' in October 2024 that its Medical Devices segment achieved an 11.7 percent increase in reported sales, driven in part by the successful adoption of its connected neuromodulation portfolio that supports seamless remote management.

Key Market Players

• Abbott Laboratories
• Medtronic plc
• Boston Scientific Corporation
• Nevro Corporation
• Stimwave LLC
• Nuvectra Corporation
• Biotronik SE & Co. KG
• Mainstay Medical International plc
• Nevro Inc.
• Sapiens Spine LLC

Report Scope

In this report, the Global Spinal Cord Stimulation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Spinal Cord Stimulation Devices Market, By Product Type

• Rechargeable v/s Non-Rechargeable

Spinal Cord Stimulation Devices Market, By Application

• Failed Back Syndrome
• Complex Regional Pain Syndrome
• Degenerative Disk Disease
• Unsuccessful Disk Surgery
• Others

Spinal Cord Stimulation Devices Market, By End User

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Spinal Cord Stimulation Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Spinal Cord Stimulation Devices Market.

Available Customizations:

Global Spinal Cord Stimulation Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Spinal Cord Stimulation Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Rechargeable v/s Non-Rechargeable)
  • 5.2.2. By Application (Failed Back Syndrome, Complex Regional Pain Syndrome, Degenerative Disk Disease, Unsuccessful Disk Surgery, Others)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Spinal Cord Stimulation Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Spinal Cord Stimulation Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Spinal Cord Stimulation Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Spinal Cord Stimulation Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Spinal Cord Stimulation Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Spinal Cord Stimulation Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. France Spinal Cord Stimulation Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Spinal Cord Stimulation Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Spinal Cord Stimulation Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Spinal Cord Stimulation Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia Pacific Spinal Cord Stimulation Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Spinal Cord Stimulation Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Spinal Cord Stimulation Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Spinal Cord Stimulation Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Spinal Cord Stimulation Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Spinal Cord Stimulation Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. Middle East & Africa Spinal Cord Stimulation Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Spinal Cord Stimulation Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Spinal Cord Stimulation Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Spinal Cord Stimulation Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. South America Spinal Cord Stimulation Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Spinal Cord Stimulation Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Spinal Cord Stimulation Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Spinal Cord Stimulation Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Spinal Cord Stimulation Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Medtronic plc
• 15.3. Boston Scientific Corporation
• 15.4. Nevro Corporation
• 15.5. Stimwave LLC
• 15.6. Nuvectra Corporation
• 15.7. Biotronik SE & Co. KG
• 15.8. Mainstay Medical International plc
• 15.9. Nevro Inc.
• 15.10. Sapiens Spine LLC

16. Strategic Recommendations

17. About Us & Disclaimer